New-Onset Uveitis Possibly Caused by Secukinumab in a 47-Year-Old Male Patient with Long-Standing Ankylosing Spondylitis.

Nadwi, Huda; Janaini, Murad; Zammo, Mohammed; Cheikh, Mohamed; Almoallim, Hani

Nadwi, Huda; Janaini, Murad; Zammo, Mohammed; Cheikh, Mohamed; Almoallim, Hani.

Afiliação

Nadwi H; Department of Medicine, College of Medicine, Umm Alqura University, Makkah, Saudi Arabia.
Janaini M; Department of Medicine, College of Medicine, Umm Alqura University, Makkah, Saudi Arabia.
Zammo M; Department of Medicine, Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia.
Cheikh M; Department of Medicine, Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia.
Almoallim H; Department of Medicine, College of Medicine, Umm Alqura University, Makkah, Saudi Arabia.

Int Med Case Rep J ; 13: 331-334, 2020.

Article em En | MEDLINE | ID: mdl-32801946

Palavras-chave

IL-17A inhibitors; ankylosing spondylitis; biologics; iritis; secukinumab; spondyloarthritis; uveitis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int Med Case Rep J Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Arábia Saudita País de publicação: Nova Zelândia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google